nivolumab · Medicine question

Which prior treatments are specified for adults receiving nivolumab (OPDIVO) alone for relapsed or refractory classical Hodgkin lymphoma?

Name: Which prior treatments are specified for adults receiving nivolumab (OPDIVO) alone for relapsed or refractory classical Hodgkin lymphoma?
Published: 2026-11-08T01:58:23.711Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Nivolumab (OPDIVO) monotherapy for adults with relapsed or refractory classical Hodgkin lymphoma is indicated after autologous stem cell transplant (ASCT) and treatment with brentuximab vedotin.

Sources for this answer

OPDIVO 10 mg/mL concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.1 Therapeutic Indications · Version 67Document updated 30 January 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about nivolumab